|
US5820873A
(en)
|
1994-09-30 |
1998-10-13 |
The University Of British Columbia |
Polyethylene glycol modified ceramide lipids and liposome uses thereof
|
|
CA2222328C
(en)
*
|
1995-06-07 |
2012-01-10 |
Inex Pharmaceuticals Corporation |
Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer
|
|
PT941066E
(pt)
|
1996-08-26 |
2004-03-31 |
Transgene Sa |
Complexos de lipido cationico - acido nucleico
|
|
US5962429A
(en)
|
1996-11-22 |
1999-10-05 |
University Of Iowa |
Complexes of adenovirus with cationic molecules
|
|
EP1903054A3
(de)
|
2001-06-05 |
2008-07-23 |
CureVac GmbH |
Stabilisierte mRNA mit erhöhtem G/C-Gehalt und optimierter Codon Usage für die Gentherapie
|
|
HUE043492T2
(hu)
|
2005-08-23 |
2019-08-28 |
Univ Pennsylvania |
Módosított nukleozidokat tartalmazó RNS és eljárások az alkalmazására
|
|
MX2011004859A
(es)
|
2008-11-07 |
2011-08-03 |
Massachusetts Inst Technology |
Lipidoides de aminoalcohol y usos de los mismos.
|
|
TR201811076T4
(tr)
|
2009-06-10 |
2018-08-27 |
Arbutus Biopharma Corp |
Geliştirilmiş lipit formulasyonu.
|
|
PL3338765T3
(pl)
|
2009-12-01 |
2019-06-28 |
Translate Bio, Inc. |
Pochodna steroidowa dla dostarczania mrna w ludzkich chorobach genetycznych
|
|
JP2014511687A
(ja)
|
2011-03-31 |
2014-05-19 |
モデルナ セラピューティクス インコーポレイテッド |
工学操作された核酸の送達および製剤
|
|
PT2717893T
(pt)
|
2011-06-08 |
2019-08-20 |
Translate Bio Inc |
Composições de nanopartículas lipídicas e métodos para transferência de arnm
|
|
ES2762873T3
(es)
|
2012-03-29 |
2020-05-26 |
Translate Bio Inc |
Lípidos catiónicos ionizables
|
|
EP3865123A1
(en)
|
2012-03-29 |
2021-08-18 |
Translate Bio, Inc. |
Lipid-derived neutral nanoparticles
|
|
WO2013185069A1
(en)
|
2012-06-08 |
2013-12-12 |
Shire Human Genetic Therapies, Inc. |
Pulmonary delivery of mrna to non-lung target cells
|
|
WO2015061467A1
(en)
|
2013-10-22 |
2015-04-30 |
Shire Human Genetic Therapies, Inc. |
Lipid formulations for delivery of messenger rna
|
|
PT3083556T
(pt)
|
2013-12-19 |
2020-03-05 |
Novartis Ag |
Lípidos e composições lipídicas para a entrega de agentes ativos
|
|
IL316479A
(en)
|
2014-06-25 |
2024-12-01 |
Acuitas Therapeutics Inc |
Novel lipids and lipid nanoparticle compositions for nucleic acid delivery
|
|
WO2016004202A1
(en)
|
2014-07-02 |
2016-01-07 |
Massachusetts Institute Of Technology |
Polyamine-fatty acid derived lipidoids and uses thereof
|
|
WO2016005004A1
(en)
|
2014-07-11 |
2016-01-14 |
Biontech Rna Pharmaceuticals Gmbh |
Stabilization of poly(a) sequence encoding dna sequences
|
|
EP3229842B1
(en)
|
2014-12-08 |
2022-07-06 |
The Board of Regents of The University of Texas System |
Lipocationic polymers and uses thereof
|
|
WO2016118724A1
(en)
|
2015-01-21 |
2016-07-28 |
Moderna Therapeutics, Inc. |
Lipid nanoparticle compositions
|
|
EP3247398A4
(en)
|
2015-01-23 |
2018-09-26 |
Moderna Therapeutics, Inc. |
Lipid nanoparticle compositions
|
|
ES2949540T3
(es)
|
2015-06-19 |
2023-09-29 |
Massachusetts Inst Technology |
2,5-piperazinadionas sustituidas con alquenilo y su uso en composiciones para suministrar un agente a un sujeto o una célula
|
|
HUE067372T2
(hu)
|
2015-06-29 |
2024-10-28 |
Acuitas Therapeutics Inc |
Lipidek és nanoszemcsés lipid formulázások nukleinsavak beadására
|
|
WO2017001570A2
(en)
|
2015-06-30 |
2017-01-05 |
Ethris Gmbh |
Atp-binding cassette family coding polyribonucleotides and formulations thereof
|
|
AU2016291228B2
(en)
|
2015-07-09 |
2020-04-09 |
Insmed Incorporated |
Compositions and methods for treating lung diseases and lung injury
|
|
CN108271360B
(zh)
|
2015-09-14 |
2023-01-24 |
得克萨斯州大学系统董事会 |
亲脂阳离子树枝状聚合物及其用途
|
|
RS63986B1
(sr)
|
2015-10-28 |
2023-03-31 |
Acuitas Therapeutics Inc |
Novi lipidi i lipidne formulacije nanočestica za isporuku nukleinskih kiselina
|
|
EP3397613A1
(en)
|
2015-12-30 |
2018-11-07 |
Acuitas Therapeutics Inc. |
Lipids and lipid nanoparticle formulations for delivery of nucleic acids
|
|
SI3436077T1
(sl)
|
2016-03-30 |
2025-07-31 |
Intellia Therapeutics, Inc. |
Formulacije lipidnih nanodelcev za komponente crispr/cas
|
|
US20190167811A1
(en)
*
|
2016-04-13 |
2019-06-06 |
Modernatx, Inc. |
Lipid compositions and their uses for intratumoral polynucleotide delivery
|
|
AU2017267634C1
(en)
|
2016-05-16 |
2022-05-26 |
The Board Of Regents Of The University Of Texas System |
Cationic sulfonamide amino lipids and amphiphilic zwitterionic amino lipids
|
|
US20170354672A1
(en)
|
2016-05-16 |
2017-12-14 |
The Board Of Regents Of The University Of Texas System |
Compositions for the delivery of trna as nanoparticles and methods of use therewith
|
|
PT3463483T
(pt)
|
2016-05-27 |
2024-03-04 |
Transcriptx Inc |
Tratamento da discinesia ciliar primária com rna do mensageiro sintético
|
|
AU2018224326B2
(en)
|
2017-02-27 |
2024-01-04 |
Translate Bio, Inc. |
Novel codon-optimized CFTR mRNA
|
|
MX2019013752A
(es)
|
2017-05-16 |
2020-07-20 |
Translate Bio Inc |
Tratamiento de la fibrosis quística mediante el suministro de arnm que codifica cftr optimizado en codones.
|
|
EP3810148A4
(en)
|
2018-06-19 |
2022-06-08 |
The Board Of Regents Of The University Of Texas System |
LIPIDAN NOPARTICLE COMPOSITIONS FOR DELIVERY OF MRNA AND LONG NUCLEIC ACIDS
|
|
EP3846822A4
(en)
|
2018-09-04 |
2022-07-06 |
The Board Of Regents Of The University Of Texas System |
COMPOSITIONS AND METHODS FOR ORGAN-SPECIFIC DELIVERY OF NUCLEIC ACIDS
|
|
GB2592504B
(en)
*
|
2018-09-04 |
2023-02-15 |
Univ Texas |
Compositions and methods for organ specific delivery of nucleic acids
|
|
EP3883592A1
(en)
|
2018-11-21 |
2021-09-29 |
Translate Bio, Inc. |
Treatment of cystic fibrosis by delivery of nebulized mrna encoding cftr
|
|
CN113412273B
(zh)
|
2019-01-07 |
2025-08-22 |
川斯勒佰尔公司 |
用于治疗原发性纤毛运动障碍的组合物和方法
|
|
US12521355B2
(en)
*
|
2019-07-12 |
2026-01-13 |
Duke University |
Nanoparticle systems for targeted delivery of CRISPR/Cas13 and methods of using same
|
|
WO2021155323A1
(en)
|
2020-01-31 |
2021-08-05 |
Beth Israel Deaconess Medical Center, Inc. |
Compositions and methods for preventing and treating coronavirus infection-sars-cov-2 vaccines
|
|
WO2021173840A1
(en)
*
|
2020-02-25 |
2021-09-02 |
Translate Bio, Inc. |
Improved processes of preparing mrna-loaded lipid nanoparticles
|
|
US12618067B2
(en)
|
2020-04-09 |
2026-05-05 |
Technische Universität München |
Targeted delivery of an inhibitor of miR-21 to macrophages for the treatment of pulmonary fibrosis
|
|
US20240293317A1
(en)
|
2020-04-20 |
2024-09-05 |
Board Of Regents, The University Of Texas System |
Lipid nanoparticle (lnp) delivery systems and uses thereof
|
|
CA3176844A1
(en)
*
|
2020-05-01 |
2021-11-04 |
Carlos G. PEREZ-GARCIA |
Nucleic acids and methods of treatment for cystic fibrosis
|
|
EP4146680A1
(en)
|
2020-05-07 |
2023-03-15 |
Translate Bio, Inc. |
Composition and methods for treatment of primary ciliary dyskinesia
|
|
JP2023538260A
(ja)
|
2020-08-06 |
2023-09-07 |
モダーナティエックス・インコーポレイテッド |
ペイロード分子を気道上皮に送達するための組成物
|
|
AU2021327782A1
(en)
*
|
2020-08-21 |
2023-03-23 |
The Board Of Regents Of The University Of Texas System |
Functional ionizable phospholipids
|
|
CN117157101A
(zh)
|
2021-02-08 |
2023-12-01 |
德克萨斯大学系统董事会 |
不饱和的树枝状聚合物组合物、有关的制剂、及其使用方法
|
|
US20240123087A1
(en)
|
2021-03-19 |
2024-04-18 |
Recode Therapeutics, Inc. |
Polynucleotide compositions, related formulations, and methods of use thereof
|
|
WO2022204053A1
(en)
|
2021-03-22 |
2022-09-29 |
Recode Therapeutics, Inc. |
Polynucleotide compositions, related formulations, and methods of use thereof
|
|
MX2023011104A
(es)
|
2021-03-22 |
2024-03-01 |
Recode Therapeutics Inc |
Composiciones de polinucleotidos, formulaciones relacionadas y metodos de uso de las mismas.
|
|
WO2022204219A1
(en)
|
2021-03-22 |
2022-09-29 |
Recode Therapeutics, Inc. |
Compositions and methods for targeted delivery to cells
|
|
MX2023011230A
(es)
|
2021-03-23 |
2023-12-06 |
Recode Therapeutics Inc |
Composiciones y metodos para administracion sistemica dirigida a celulas.
|
|
KR20230175196A
(ko)
|
2021-03-23 |
2023-12-29 |
리코드 테라퓨틱스, 인크. |
폴리뉴클레오티드 조성물, 관련된 제제, 및 이의 사용 방법
|
|
CA3213308A1
(en)
|
2021-04-05 |
2022-10-13 |
Daniel J. Siegwart |
Compositions, methods and uses for treating cystic fibrosis and related disorders
|
|
WO2022226344A1
(en)
|
2021-04-22 |
2022-10-27 |
The Board Of Regents Of The University Of Texas System |
All-in-one dendrimer-based lipid nanoparticles enable precise hdr-mediated gene editing in vivo
|
|
EP4352240A4
(en)
|
2021-06-09 |
2025-07-09 |
Recode Therapeutics Inc |
POLYNUCLEOTIDE COMPOSITIONS, RELATED FORMULATIONS AND METHODS OF USE THEREOF
|